These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25457462)

  • 1. A clinical screening score for diabetic polyneuropathy: KORA F4 and AusDiab studies.
    Bongaerts BW; Ziegler D; Shaw JE; Heier M; Kowall B; Herder C; Roden M; Peters A; Meisinger C; Rathmann W
    J Diabetes Complications; 2015; 29(1):44-9. PubMed ID: 25457462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential associations between selenoprotein P and distal sensorimotor polyneuropathy in people with and without diabetes: KORA F4/FF4 study.
    Herder C; Saito Y; Spagnuolo MC; Maalmi H; Shimizu M; Bönhof GJ; Suzuki K; Rathmann W; Peters A; Roden M; Ziegler D; Thorand B; Takamura T
    Free Radic Biol Med; 2024 Oct; 223():87-95. PubMed ID: 39059514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between multiple neurological biomarkers and distal sensorimotor polyneuropathy: KORA F4/FF4 study.
    Herder C; Thorand B; Strom A; Rathmann W; Heier M; Koenig W; Morrison H; Ziegler D; Roden M; Peters A; Bönhof GJ; Maalmi H
    Diabetes Metab Res Rev; 2024 Jul; 40(5):e3807. PubMed ID: 38872492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of screening questionnaires and risk scores for undiagnosed diabetes: the KORA Survey 2000.
    Rathmann W; Martin S; Haastert B; Icks A; Holle R; Löwel H; Giani G;
    Arch Intern Med; 2005 Feb; 165(4):436-41. PubMed ID: 15738374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research letter in relation to paper by Bongaerts et al., a clinical screening score for diabetic polyneuropathy: KORA F4 and AusDiab studies.
    Lomova-Williams L; Mallipedhi A; MacIver C; Price DE; Thomas R; Ferguson C; Stephens JW
    J Diabetes Complications; 2015 Mar; 29(2):318-9. PubMed ID: 25498301
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to research letter in relation to paper by Bongaerts et al., a clinical screening score for diabetic polyneuropathy: KORA F4 and AusDiab studies (a single question screening test for the detection of diabetic peripheral neuropathy).
    Bongaerts BW; Ziegler D; Shaw JE; Rathmann W
    J Diabetes Complications; 2015 Mar; 29(2):319. PubMed ID: 25498299
    [No Abstract]   [Full Text] [Related]  

  • 7. Proinflammatory Cytokines Predict the Incidence and Progression of Distal Sensorimotor Polyneuropathy: KORA F4/FF4 Study.
    Herder C; Kannenberg JM; Huth C; Carstensen-Kirberg M; Rathmann W; Koenig W; Heier M; Püttgen S; Thorand B; Peters A; Roden M; Meisinger C; Ziegler D
    Diabetes Care; 2017 Apr; 40(4):569-576. PubMed ID: 28174259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can a screening programme for diabetes be applied to another population?
    Glümer C; Borch-Johnsen K; Colagiuri S
    Diabet Med; 2005 Sep; 22(9):1234-8. PubMed ID: 16108854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10).
    Kamiya H; Himeno T; Watarai A; Baba M; Nishimura R; Tajima N; Nakamura J
    J Diabetes Investig; 2024 Feb; 15(2):247-253. PubMed ID: 38213265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of clinical tools and their diagnostic use in distal symmetric polyneuropathy.
    Pourhamidi K; Dahlin LB; Englund E; Rolandsson O
    Prim Care Diabetes; 2014 Apr; 8(1):77-84. PubMed ID: 23664849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Older subjects with diabetes and prediabetes are frequently unaware of having distal sensorimotor polyneuropathy: the KORA F4 study.
    Bongaerts BW; Rathmann W; Heier M; Kowall B; Herder C; Stöckl D; Meisinger C; Ziegler D
    Diabetes Care; 2013 May; 36(5):1141-6. PubMed ID: 23275355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
    Dohrn MF; Othman A; Hirshman SK; Bode H; Alecu I; Fähndrich E; Karges W; Weis J; Schulz JB; Hornemann T; Claeys KG
    Eur J Neurol; 2015 May; 22(5):806-14, e55. PubMed ID: 25623782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloperoxidase, superoxide dismutase-3, cardiometabolic risk factors, and distal sensorimotor polyneuropathy: The KORA F4/FF4 study.
    Herder C; Kannenberg JM; Huth C; Carstensen-Kirberg M; Rathmann W; Koenig W; Strom A; Bönhof GJ; Heier M; Thorand B; Peters A; Roden M; Meisinger C; Ziegler D
    Diabetes Metab Res Rev; 2018 Jul; 34(5):e3000. PubMed ID: 29577557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of diagnosed and undiagnosed polyneuropathy in subjects with and without diabetes participating in a nationwide educational initiative (PROTECT study).
    Ziegler D; Strom A; Lobmann R; Reiners K; Rett K; Schnell O
    J Diabetes Complications; 2015; 29(8):998-1002. PubMed ID: 26482177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low serum omentin levels in the elderly population with Type 2 diabetes and polyneuropathy.
    Herder C; Bongaerts BW; Ouwens DM; Rathmann W; Heier M; Carstensen-Kirberg M; Koenig W; Thorand B; Roden M; Meisinger C; Ziegler D;
    Diabet Med; 2015 Nov; 32(11):1479-83. PubMed ID: 26094489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between distal sensorimotor polyneuropathy and cardiovascular complications in diabetic patients in the North-Eastern region of Hungary.
    Pető A; Tóth LI; Hernyák M; Lőrincz H; Molnár Á; Nagy AC; Lukács M; Kempler P; Paragh G; Harangi M; Ferenc S
    PLoS One; 2024; 19(7):e0306482. PubMed ID: 38959204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of polyneuropathy in diabetes and prediabetes.
    Ziegler D; Papanas N; Vinik AI; Shaw JE
    Handb Clin Neurol; 2014; 126():3-22. PubMed ID: 25410210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Autonomic Neuropathy and Distal Symmetric Sensorimotor Polyneuropathy: These Two Diabetic Microvascular Complications do not Invariably Co-Exist.
    Pafili K; Trypsianis G; Papazoglou D; Maltezos E; Papanas N
    Curr Vasc Pharmacol; 2020; 18(1):50-56. PubMed ID: 30156161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of clinical alternatives to nerve conduction studies for screening for diabetic distal symmetrical polyneuropathy: A multi-center study.
    Zhao Z; Ji L; Zheng L; Yang L; Yuan H; Chen L; Shan Z; Shen S; Li Q; Shi B; Liu Y; Ji Q; Bao Y; Gao X; Xie Y; Liu Y; Chen L; Han X; Wu F; Yang C; Du J; Gao Y; Zou D
    Diabetes Res Clin Pract; 2016 May; 115():150-6. PubMed ID: 27116903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy.
    Maalmi H; Strom A; Petrera A; Hauck SM; Strassburger K; Kuss O; Zaharia OP; Bönhof GJ; Rathmann W; Trenkamp S; Burkart V; Szendroedi J; Ziegler D; Roden M; Herder C;
    Diabetologia; 2023 Mar; 66(3):579-589. PubMed ID: 36472640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.